Regulus Therapeutics (NASDAQ:RGLS) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 65.22 percent increase over losses of $(0.23) per share from the same period last year.
GM Ties Up With Warren Buffett-Backed Firm To Build National EV Charging Network
Automotive company General Motors (NYSE: GM) is stepping up its electric vehicle game with a new plan to build a coast-to-coast fast charging network. Here are the details and how a Warren Buffett-backed company is helping.
